Bryn Mawr Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.13M Buy
8,882
+7
+0.1% +$2.5K 0.15% 122
2025
Q4
$2.91M Sell
8,875
-423
-5% -$134K 0.14% 127
2025
Q3
$2.62M Sell
9,298
-690
-7% -$200K 0.13% 130
2025
Q2
$2.79M Sell
9,988
-1,619
-14% -$459K 0.15% 122
2025
Q1
$3.62M Sell
11,607
-646
-5% -$191K 0.22% 102
2024
Q4
$3.19M Sell
12,253
-476
-4% -$141K 0.17% 117
2024
Q3
$4.1M Buy
12,729
+26
+0.2% +$8.51K 0.22% 99
2024
Q2
$3.97M Sell
12,703
-57
-0.4% -$16.7K 0.22% 101
2024
Q1
$3.63M Sell
12,760
-902
-7% -$264K 0.21% 105
2023
Q4
$3.93M Sell
13,662
-5,491
-29% -$1.5M 0.25% 94
2023
Q3
$5.15M Buy
19,153
+11,104
+138% +$2.77M 0.34% 74
2023
Q2
$1.79M Sell
8,049
-655
-8% -$152K 0.17% 121
2023
Q1
$2.1M Sell
8,704
-157
-2% -$38.5K 0.22% 104
2022
Q4
$2.33M Buy
8,861
+1,796
+25% +$481K 0.25% 94
2022
Q3
$1.59M Sell
7,065
-51
-0.7% -$12.4K 0.56% 42
2022
Q2
$1.73M Sell
7,116
-112
-2% -$27.4K 0.57% 39
2022
Q1
$1.75M Buy
+7,228
New +$1.66M 0.49% 53

Other funds holding AMGN

Bryn Mawr Capital Management's AMGN Position: Q1 2026 in Review

Bryn Mawr Capital Management increased its Amgen (AMGN) stake by 0.08% in Q1 2026, buying an estimated $2.5K and bringing the position to 8,882 shares worth $3.13M. The position accounts for 0.15% of the portfolio, ranked #122.

Bryn Mawr Capital Management first reported a position in AMGN in Q1 2022 and has held it in 17 quarters since. The position peaked at $5.15M in Q3 2023. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Bryn Mawr Capital Management held 8,882 shares of Amgen worth $3.13M as of Q1 2026.
  • Bryn Mawr Capital Management bought 7 Amgen shares in Q1 2026, an estimated $2.5K.
  • Amgen made up 0.15% of Bryn Mawr Capital Management's portfolio in Q1 2026, its #122 holding.
  • Bryn Mawr Capital Management first reported a position in Amgen in Q1 2022 and has held it in 17 quarters since.
  • Bryn Mawr Capital Management's Amgen position peaked at $5.15M in Q3 2023.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Bryn Mawr Capital Management's 13F filing for Q1 2026, filed 4 May 2026.